Internship

Software Engineering Intern

Posted on 2/11/2025

Resmed

Resmed

5,001-10,000 employees

Develops cloud-connected medical devices for chronic diseases

Compensation Overview

$22.50 - $41.50/hr

No H1B Sponsorship

San Diego, CA, USA

This is a hybrid role requiring on-site participation for team meetings.

Category
Full-Stack Engineering
Software Engineering
Required Skills
Python
Java
C/C++
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Resmed referral from your network.

đź’ˇ

Applications through a referral are 3x more likely to get an interview!

Requirements
  • Ability to work full-time for 12 weeks during Summer 2025; program dates are May 19, 2025 – August 8, 2025 OR June 16, 2025 – September 5, 2025
  • Computer Science academic studies that will lead to a Bachelor's or Master's Degree (Computer Science, Software Engineering, or Electrical Engineering)
  • Experience with programming languages such as Java, Python, or C++
Responsibilities
  • Developing and enhancing software solutions for medical devices
  • Improving user experience and device performance
Desired Qualifications
  • Excellent critical thinking and problem-solving skills.
  • Strong experiences as demonstrated through projects, research or software engineering internships
  • Great interpersonal relations, team cooperation and communication skills.
  • Exceptional organizational and collaboration skills as demonstrated through leadership positions on teams and/or in student or civic organizations
  • Exceptional communication skills and interest and enthusiasm related to medical technology industry and a career with ResMed

ResMed develops medical devices and software platforms designed to treat and manage conditions like sleep apnea and chronic obstructive pulmonary disease (COPD). Their products are cloud-connected, allowing for better monitoring and management of patients' health. ResMed's offerings include both medical devices and software subscriptions, which generate revenue through product sales and ongoing service fees. What sets ResMed apart from its competitors is its focus on reducing hospital visits and healthcare costs while improving the quality of life for patients. The company's goal is to provide effective solutions for patients, healthcare professionals, and caregivers across more than 120 countries.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • The wearable health tech market expansion boosts ResMed's market penetration.
  • Rising demand for COPD management solutions presents growth opportunities for ResMed.
  • Telehealth expansion enhances ResMed's cloud-connected devices and software platforms.

What critics are saying

  • Emerging digital health startups may erode ResMed's market share.
  • Rapid technological advancements require continuous R&D investment, impacting profit margins.
  • Global semiconductor shortage could disrupt ResMed's production and supply chain.

What makes Resmed unique

  • ResMed integrates AI in sleep apnea diagnosis, enhancing accuracy and efficiency.
  • The company focuses on home-based care, aligning with industry trends.
  • ResMed's cloud-connected devices offer comprehensive remote patient monitoring solutions.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

Parental Leave

401(k) Retirement Plan

Employee Assistance Program (EAP)

Company News

KirkpatrickPrice
May 6th, 2025
One Audit Firm, One Platform: Resmed's Journey to Settling Down

To bring consistency scalability, and simplicity to their audit engagements, Resmed partnered with KirkpatrickPrice.

GlobeNewswire
May 1st, 2025
Resmed Acquires Virtuox

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced it has acquired VirtuOx, a leading independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions.The acquisition reflects Resmed’s commitment to improving the way care is delivered—by making it more accessible, more coordinated, and more patient friendly. With VirtuOx’s at-home diagnostic services, Resmed will be better positioned to support patients earlier in their journey and help healthcare providers and homecare companies deliver care in a simpler, more connected way.VirtuOx’s virtual testing platform helps reduce barriers to diagnosis, offering fast, flexible, and affordable options for patients—particularly those with sleep-disordered breathing or other conditions that are often underdiagnosed. For people suspected of having obstructive sleep apnea (OSA), a more streamlined, digital-first experience can make the difference between following through on testing and treatment—or falling out of the care pathway entirely.“This is about creating a simpler, more connected pathway to care,” said Justin Leong, Chief Product Officer at Resmed. “By integrating VirtuOx’s diagnostic capabilities into our ecosystem, we can help accelerate the time between evaluation and treatment, reduce drop-off, and help more people access the life-changing benefits of therapy for sleep apnea and related conditions.”This acquisition strengthens Resmed’s ability to partner with healthcare providers to help streamline the diagnostic process and alleviate current bottlenecks, while expanding collaboration with home medical equipment providers to efficiently and expeditiously support patients to start treatment. It further enhances the company’s ability to serve healthcare providers with integrated tools that improve care coordination, patient engagement, and outcomes.“VirtuOx and Resmed are aligned in our focus to simplify healthcare and expand access,” said Steve Lica, CEO of VirtuOx. “Joining Resmed gives us the opportunity to scale our impact, reach and help more patients, and keep innovating on behalf of the providers and health systems we serve.”The acquisition supports a growing demand for home-based care—driven by increased awareness, convenience, and digital innovation

IR Impact
Apr 24th, 2025
Resmed names Salli Schwartz as chief investor relations officer

Healthcare technology provider Resmed has named Salli Schwartz as its chief investor relations officer.

Veye
Apr 24th, 2025
Top ASX Stocks Get a Lift Post Strong Quarters

ResMed was also recognized as one of LexisNexis "Top 100 Global Innovators."

Fierce Biotech
Apr 4th, 2025
Resmed debuts wearable, at-home sleep apnea test

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.

INACTIVE